Assembly Biosciences Executives Buy Shares in Planned RSU Move, Hinting at Confidence in HBV-Cure Pipeline
Assembly Biosciences insider buys reveal confidence in HBV‑cure trials and a long‑term strategy, offering investors a cautious bullish signal amid market volatility.
4 minutes to read